Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/36871
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease |
Autor: | Ivorra, Carmen CSIC ORCID; Samyn, H.; Edo, María Dolores; Castro, Claudia; Sanz-González, Silvia M. CSIC; Díez-Juan, Antonio CSIC ORCID; Andrés, Vicente CSIC ORCID | Palabras clave: | Cyclin-dependent kinase Cdk/cyclins Cdk family CkI CDK inhibitors |
Fecha de publicación: | feb-2003 | Editor: | Bentham Science Publishers | Citación: | Current Pharmaceutical Biotechnology 4(1): 21-37 (2003) | Resumen: | Excessive cell proliferation contributes to the pathobiology of human diseases with a high health and socioeconomic impact, including cancer and vascular occlusive diseases (e.g., atherosclerosis, in-stent restenosis, transplant vasculopathy, and vessel bypass graft failure). Recent advances in the understanding of the molecular networks governing the hyperplastic growth of tumors and vascular obstructive neointimal lesions have provided new perspectives for preventive and therapeutic strategies against these disorders. Mammalian cell proliferation requires the activation of several cyclin-dependent protein kinases (CDKs). Postranslational activation of CDKs is a complex process that involves their association with regulatory subunits called cyclins. The activity of CDK / cyclin holoenzymes is negatively regulated through their interaction with members of the CDK family of inhibitory proteins (CKIs). Moreover, over fifty low molecular weight pharmacological CDK inhibitors that target the ATP-binding pocket of the catalytic site of CDKs have been identified. In this review, we will discuss the use of pharmacological and gene therapy strategies against CDK / cyclins in animal models and clinical trials of cancer and cardiovascular disease. | Descripción: | 17 páginas.-- El documento en word es la versión post-print. | Versión del editor: | http://www.benthamdirect.org/pages/content.php?CPB/2003/00000004/00000001/0002G | URI: | http://hdl.handle.net/10261/36871 | ISSN: | 1389-2010 |
Aparece en las colecciones: | (IBV) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Curr. Pharm. Biotechnol. 4 21-37 (2003).doc | 396 kB | Microsoft Word | Visualizar/Abrir |
CORE Recommender
Page view(s)
361
checked on 18-abr-2024
Download(s)
269
checked on 18-abr-2024
Google ScholarTM
Check
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.